An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension

NCT01560637 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

471

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: UT-15C (treprostinil diolamine)

Sponsor

United Therapeutics